Clinical Trial Update: Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab plus stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN